Clinical Trial Update: The Effect of Farlong® NotoGinseng™ (Ginseng Plus®) on Cholesterol and Blood Pressure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Farlong NotoGinseng (Ginseng Plus) for effects on cholesterol and blood pressure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemias
• Hypertension

Drugs mentioned

• Farlong NotoGinseng (Ginseng Plus)

Snippet

Sponsor: LongStar HealthPro, Inc. DBA Farlong Pharmaceutical | Conditions: Hyperlipidemias, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-12-30